Psilocybin-Research.comSearchable psilocybin and psilocin bibliometric database.Researcher index
Authors in the psilocybin and psilocin literature
Search researcher names, inspect publication history, find recurring topics, and create author watch alerts without collecting unverified contact lists.
Publication history
Global increases in brain glucose metabolism following acute N,N-dimethyltryptamine and harmine administration in healthy volunteers: A randomised [F]FDG-PET study.Journal of cerebral blood flow and metabolism: official journal of the International Society of Cerebral Blood Flow and Metabolism · 2026-06-01Sa1731 A PILOT STUDY OF OPEN-LABEL PSILOCYBIN-ASSISTED THERAPY IN TREATMENT-REFRACTORY IBSGastrointestinal Endoscopy · 2026-05-01Impact of psilocybin and Psilocybe cubensis extract on gut microbiota in Wistar Han ratsScience Letters · 2026-04-17Psilocybin and Psilocybe cubensis extract exhibit divergent behavioural and toxicological effects in ratsScience Letters · 2026-04-17Psilocybin: Wirksam, aber kein WundermittelMMW - Fortschritte der Medizin · 2026-04-01Psychedelic-assisted therapy: a survey on the clinical methods of Swiss physicians.Therapeutic advances in psychopharmacology · 2026-01-01Home-based psilocybin-assisted therapy for a patient with advanced cancer: A case report.Palliative & supportive care · 2025-10-23Control Group Outcomes in Trials of Psilocybin, SSRIs, or Esketamine for Depression: A Meta-Analysis.JAMA network open · 2025-07-01Exploring psilocybin's role in mental health and palliative medicine: a path to improved well-being.Expert opinion on emerging drugs · 2025-06-01Further education in psychedelic-assisted therapy - experiences from Switzerland.BMC medical education · 2025-03-05Prolonged adverse effects from repeated psilocybin use in an underground psychedelic therapy training program: a case report.BMC psychiatry · 2025-02-28Implementing psychedelic-assisted therapy: History and characteristics of the Swiss limited medical use program.Neuroscience applied · 2025-01-01Psychedelics for the Treatment of Obsessive-Compulsive Disorder: Efficacy and Proposed Mechanisms.The international journal of neuropsychopharmacology · 2024-12-01Meditating on psychedelics. A randomized placebo-controlled study of DMT and harmine in a mindfulness retreat.Journal of psychopharmacology (Oxford, England) · 2024-10-01Mind the Psychedelic Hype: Characterizing the Risks and Benefits of Psychedelics for DepressionPsychoactives · 2024-04-15Psychedelika-assistierte PsychotherapieDie Psychotherapie · 2024-02-28A Single Method for 127 Recommended and Additional DUID Drugs in Blood and Urine by LC-MS-MS.Journal of analytical toxicology · 2022-07-14LSD Increases Primary Process Thinking via Serotonin 2A Receptor Activation.Frontiers in pharmacology · 2017-01-01Effects of the hallucinogen psilocybin on covert orienting of visual attention in humans.Neuropsychobiology · 2002-01-01Neurometabolic effects of psilocybin, 3,4-methylenedioxyethylamphetamine (MDE) and d-methamphetamine in healthy volunteers. A double-blind, placebo-controlled PET study with [18F]FDG.Neuropsychopharmacology: official publication of the American College of Neuropsychopharmacology · 1999-06-01Psychopathological, neuroendocrine and autonomic effects of 3,4-methylenedioxyethylamphetamine (MDE), psilocybin and d-methamphetamine in healthy volunteers. Results of an experimental double-blind placebo-controlled study.Psychopharmacology · 1999-02-01Psilocybin induces schizophrenia-like psychosis in humans via a serotonin-2 agonist action.Neuroreport · 1998-12-01Effects of the hallucinogen psilocybin on habituation and prepulse inhibition of the startle reflex in humans.Behavioural pharmacology · 1998-11-01529 The hallucinogen psilocybin increases prepulse inhibition of the startle reflex in healthy humansInternational Journal of Psychophysiology · 1998-09-01Methodological issues of human experimental research with hallucinogens.Pharmacopsychiatry · 1998-07-01